Lung, Epithelium – Necrosis



comment:
Necrosis ( Figure 1






The anatomic location of necrotic lesions may vary due to the physicochemical properties of the test agent or the susceptibility of a particular cell type to the test agent. The epithelium of the terminal bronchioles and alveolar ducts (i.e., the centriacinar region) and alveoli are particularly susceptible to injury due to the large surface area and fragility of the alveolar type I cells, the metabolic activity of P450 enzymes in Clara cells, and the generally thinner mucous layer.
recommendation:
Lung, Epithelium - Necrosis should be diagnosed and graded whenever present. A site modifier should be included in the diagnosis to indicate the location of the lesion within the lung (e.g., alveolus, bronchiole) since toxic insults can preferentially target specific sites. If more than one site is affected, the site modifier may be omitted and the locations described in the pathology narrative. There is significant overlap, morphologically, between degeneration and necrosis, so the pathologist will need to use his or her best judgment when diagnosing these lesions. If the necrosis is secondary to another process, such as severe inflammation, it is preferable to diagnose the major process and to describe the necrosis in the narrative. If the necrosis and a concurrent, related lesion (e.g., inflammation) are both prominent, the pathologist may choose to record both lesions and grade them separately. Again, the pathologist will need to use his or her judgment in deciding whether or not to diagnose the necrosis or degeneration separately. If the necrotic cells have detached, exposing the underlying tissue, the term "ulcer" or "erosion" should be used (see Lung - Ulceration). However, if the necrotic cells are still present and covering the basement membrane, necrosis is the preferred diagnosis.related links:
Lung - Ulcerationreferences:
Boorman GA, Eustis SL. 1990. Lung. In: Pathology of the Fischer Rat: Reference and Atlas (Boorman GA, Eustis SL, Elwell MR, Montgomery CA, MacKenzie WF, eds). Academic Press, San Diego, CA, 339-367.
Haschek-Hock WM, Witschi HP. 1990. Respiratory system. In: Handbook of Toxicologic Pathology (Haschek-Hock WM, CG Rousseaux, eds). Academic Press, San Diego, CA, 761-827.
Kumar V, Abbas AK, Fausto N. 2005. Cellular adaptations, cell injury, and cell death. In: Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier Saunders, Philadelphia, 3-48.
Lopez A. 2007. Respiratory system. In: Pathologic Basis of Veterinary Disease, 4th ed (McGavin MD, Zachary JF, eds). Mosby, St Louis, 463-558.
Plopper CG, Dungworth DL. 197. Structure, function, cell injury and cell renewal of bronchiolar and alveolar epithelium. In: Lung Carcinomas (McDowell EM, ed). Churchill Livingstone, Edinburgh, 94-128.
Renne, R, Brix A, Harkema J, Herbert R, Kittle B, Lewis D, March T, Nagano K, Pino M, Rittinghausen S, Rosenbruch M, Tellier P, Wohrmann T. 2009. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol 37(suppl):5S-73S. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20032296
Web page last updated on: December 03, 2015